DVAX stock


Dynavax Technologies Corporation (DVAX) Announces the Launch of HEPLISAV-B in the US

Dynavax Technologies Corporation (NASDAQ:DVAX) announced that HEPLISAV-B™ (Hepatitis B Vaccine) for the prevention of hepatitis B in adults is now available for prescription in the …

Dynavax Technologies Corporation (DVAX) Is Looking at a “Long Commercial Life” Ahead for Its Just-Approved Hepatitis B Vaccine

Cowen believes Dynavax has an asset on its hands that fulfills a valuable unmet need.

Dynavax Technologies Corporation’s (DVAX) Hepatitis B Vaccine Wins FDA Approval

Dynavax Technologies Corporation (NASDAQ:DVAX) has won U.S.

Dynavax Technologies Corporation (DVAX) Announces Dosing of First Subject in Phase 1b Study of DV281

Dynavax Technologies Corporation (NASDAQ:DVAX) announced initiation of dosing in patients with non-small cell lung cancer (NSCLC). This multi-center, open label trial is designed …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts